OncoSemiDx is an AI-powered semiconductor biosensing system that enables fast, affordable, and highly sensitive early cancer detection at the point of care.
OncoSemiDx is an innovative diagnostic platform that combines artificial intelligence, genomic analysis, and semiconductor biosensor technology to enable early cancer detection. The system uses a CMOS-based lab-on-chip sensor that captures cancer biomarkers and converts them into measurable electrical signals. These signals are then processed using deep learning models and advanced noise analysis algorithms to accurately identify cancer-related patterns even at very low biomarker concentrations. By integrating AI-driven genomic analysis with portable biosensing hardware, the platform provides rapid, cost-effective, and scalable cancer screening that can be deployed in hospitals, clinics, and resource-limited healthcare settings.